Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow

Blood

Volumn 106, Issue 1, 2005, Pages 141-143

  Tao, Zhenyin ^b   Wang, Yongtao ^b   Choi, Huiwei ^b   Bernardo, Aubrey ^b   Nishio, Kenji ^b   Sadler, J Evan ^b   López, José A ^b   Dong, Jing Fei ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; PROCOLLAGEN C PROTEINASE; RECOMBINANT ENZYME; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BLOOD; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PLASMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; THROMBOTIC THROMBOCYTOPENIC PURPURA; UMBILICAL VEIN;

EID: 22044446207     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-11-4188     Document Type: Article

References (19)

1. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307:1432-1435.
2. Moake JL. Thrombotic thrombocytopenic purpura: the systemic clumping "plague." Annu Rev Med. 2002;53:75-88.
3. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001;98:1654-1661.
4. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996;87:4223-4234.
5. Dent JA, Galbusera M, Ruggeri ZM. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest. 1991;88:774-782.
6. Furlan M. Von Willebrand factor: molecular size and functional activity. Ann Hematol. 1996;72:341-348.
7. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589-600.
8. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488-494.
9. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100:4033-4039.
10. Padilla A, Moake JL, Bernardo A, et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004;103:2150-2156.
11. Zheng X, Nishio K, Majerus EM, Sadler JE. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS-13. J Biol Chem. 2003;278:30136-30141.
12. Soejima K, Matsumoto M, Kokame K, et al. ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood. 2003;102:3232-3237.
13. Dong JF, Bernardo A, Nolasco L et al. ADAMTS-13 proteolysis of ultra-large von Willebrand factor multimers on the endothelial surface requires protease docking and is inhibited by thrombospondin-1 [abstract]. Blood. 2002;100:123a.
14. Zhang W, Motto D, Ginsburg D. ADAMTS-13 binds VWF via its C-terminal CUB2 domain [abstract]. Blood. 2004;104:39a.
15. Majerus EM, Anderson PJ, Sadler JE. Characterization of the binding interaction between ADAMTS-13 and von Willebrand factor [abstract]. 2005;104:150a.
16. Gao G, Westling J, Thompson VP, Howell TD, Gottschall PE, Sandy JD. Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem. 2002;277:11034-11041.
17. Kashiwagi M, Enghild JJ, Gendron C, et al. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem. 2003;279:10109-10119.
18. Dong JF, Whitelock J, Bernardo A, Ball C, Cruz MA. Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow. J Thromb Haemost. 2004;2:1460-1466.
19. Nishio K, Anderson PJ, Zheng XL, Sadler JE. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS-13. Proc Natl Acad Sci USA. 2004;101:10578-10583.